Question: what is known about those infected with Covid-19 but are asymptomatic?

SARS-CoV-2 (COVID-19): What do we know about children? A systematic review

Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks

There are asymptomatic and pre-symptomatic patients infected with COVID-19. So what? Pandemic response implications

Asymptomatic COVID-19: What the Neuroradiologist Needs to Know about Pulmonary Manifestations.

Management of non traumatic surgical emergencies during the COVID-19 pandemia

Audiological profile of asymptomatic Covid-19 PCR-positive cases

Human and novel coronavirus infections in children: a review

Human and novel coronavirus infections in children: a review.

Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

Protective immunity after COVID-19 has been questioned: what can we do without SARS-CoV-2-IgG detection?

The COVID-19 infection control arms race

COVID-19, Negligence and Occupational Health and Safety: Ethical and Legal Issues for Hospitals and Health Centres.

ACE 2 Coding Variants: A Potential X-linked Risk Factor for COVID-19 Disease

A Review of Asymptomatic and Subclinical Middle East Respiratory Syndrome Coronavirus Infections

To mask or not to mask children to overcome COVID-19

The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.

Understand Research Hotspots Surrounding COVID-19 and Other Coronavirus Infections Using Topic Modeling

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID‐19: Meta‐analysis and sensitivity analysis

Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study

Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate forCOVID-19: Meta-analysis and sensitivity analysis

COVID-19 and the Heart.

COVID-19 and the Heart

Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach

Covid-19 in pregnant women and babies: What pediatricians need to know

The COVID-19 (SARS-CoV-2) Uncertainty Tripod in Brazil: Assessments on model-based predictions with large under-reporting

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

The natural history and transmission potential of asymptomatic SARS-CoV-2 infection

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls.

What orthopedic surgeons need to know about Covid-19 pandemic

What orthopedic surgeons need to know about Covid-19 pandemic()

Lived experiences of the Corona Survivors (patients admitted in COVID wards): A Narrative real-life documented summaries of internalized guilt, shame, stigma, anger

Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger

The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis

Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy

Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy.

Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected-Narrative Review Article

Chest Computed Tomography Findings in Asymptomatic Patients with COVID-19

Asymptomatic SARS-CoV-2 infection and COVID-19 mortality during an outbreak investigation in a skilled nursing facility

Asymptomatic COVID-19 Have Longer Treatment Cycle Than Moderate Type of Confirmed Patients

SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?

COVID-19 – What does a paediatrician need to know?

Adding the missing sugars to coronavirus protein structures

2019 Novel Coronavirus: What Is Currently Known, Cardiovascular Implications and Management

2019 novel coronavirus: what is currently known, cardiovascular implications and management.

Is there an airborne component to the transmission of COVID-19? : a quantitative analysis study

Fighting COVID-19 Misinformation on Social Media: Experimental Evidence for a Scalable Accuracy-Nudge Intervention.

From SARS to COVID-19: What we have learned about children infected with COVID-19

Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy

Outcome of COVID‐19 in liver transplant recipients: A preliminary report from Northwestern Italy

Coronaviruses: important emerging human pathogens.

A Letter to the Future AWWA

Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes

Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know

Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China

Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known?

On the evolutionary epidemiology of SARS-CoV-2

Thinking about “Thinking about COVID-19”

The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles

Point-of-care lung ultrasound in three neonates with COVID-19

EFFECTS OF COVID-19 INFECTION DURING PREGNANCY AND NEONATAL PROGNOSIS: WHAT IS THE EVIDENCE?

Risk factors for disease progression in COVID-19 patients

Cytokine storm and the prospects for immunotherapy with COVID-19.

Cytokine storm and the prospects for immunotherapy with COVID-19

COVID-19 and the difficulty of inferring epidemiological parameters from clinical data

What We Learned about COVID-19 So Far? Notes from Underground

What We Learned about COVID-19 So Far? Notes from Underground.

A cluster of COVID-19 in pilgrims to Israel

[Asymptomatic and pre-symptomatic cases of COVID-19 contribution to spreading the epidemic and need for targeted control strategies].

COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals

Detection of respiratory viruses in gargle specimens of healthy children

Use of systemic therapies for psoriasis in the COVID-19 era.

Use of systemic therapies for psoriasis in the COVID-19 era

COVID-19: asymptomatic carrier transmission is an underestimated problem

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China Dong Y, Mo X, Hu Y, et al. Pediatrics. 2020; doi: 10.1542/peds.2020-0702.

Middle East respiratory syndrome coronavirus in healthcare settings.

General Surgery Operating Room Practice in Patients with COVID-19

Prevalence of SARS-CoV-2 infection among asymptomatic healthcare workers in greater Houston: a cross-sectional analysis of surveillance data from a large healthcare system

Pre-Procedural Surveillance Testing for SARS-CoV-2 in an Asymptomatic Population Shows Low Rates of Positivity

COVID-19 in Children: An Ample Review

A Systematic Review of Cases of Acute Respiratory Distress Syndrome in the Coronavirus Disease 2019 Pandemic

Immunological determinants of clinical outcomes in COVID-19: A quantitative perspective

Organ donation during the coronavirus pandemic: an evolving saga in uncharted waters

Near-term pregnant women's attitude toward, concern about and knowledge of the COVID-19 pandemic.

Predicting COVID-19 spread and public health needs to contain the pandemic in West-Africa


Question: what evidence is there for the value of hydroxychloroquine in treating Covid-19?

Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?

Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

QT prolongation, torsades de pointes and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: a systematic review

Ethical issues related to the hydroxychloroquine treatment prescription for Covid-19

Potential therapeutic agents against COVID-19: What we know so far

Former FDA leaders decry emergency authorization of malaria drugs for coronavirus

Should azithromycin be used to treat COVID-19? A rapid review

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine

Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19 Infection- A Systematic Literature Review

Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).

The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?

Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients

[Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection].

[Lack of clinical evidence for the use of hydroxychloroquine to treat SARS-CoV-2 infection]

Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine

Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

Rethinking the role of hydroxychloroquine in the treatment of COVID-19

Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study

Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients

Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.

Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.

Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?

Quantifying treatment effects of hydroxychloroquine and azithromycin for COVID-19: a secondary analysis of an open label non-randomized clinical trial (Gautret et al, 2020)

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review

Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update

Chloroquine, hydroxychloroquine, and COVID-19: systematic review and narrative synthesis of efficacy and safety

Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al

Chloroquine and hydroxychloroquine effectiveness in human subjects during coronavirus: a systematic review

Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.

Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review

Experience with Hydroxychloroquine and Azithromycin in the COVID-19 Pandemic: Implications for QT Interval Monitoring.

Serious Adverse Events Associated With Hydroxychloroquine Amidst COVID-19 Pandemic: Case Series and Literature Review

Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19

Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

Intentional Hydroxychloroquine Overdose Treated with High-Dose Diazepam: an Increasing Concern in the COVID-19 Pandemic

Model informed dosing of Hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and Gaps.

Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence

Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence.

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis of confounder-adjusted 20212 hospitalized patients

Practice considerations on the use of investigational anti‐COVID‐19 medications: Dosage, administration and monitoring

Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring

The ICMR bulletin on targeted hydroxychloroquine prophylaxis for Covid-19: Need to interpret with caution.

Efficacy and Safety of Hydroxychloroquine and Chloroquine for COVID-19: A systematic review

Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studies

Chloroquine, hydroxychloroquine and COVID-19

Outcomes of Hydroxychloroquine Treatment Among Hospitalized COVID-19 Patients in the United States- Real-World Evidence From a Federated Electronic Medical Record Network

Hydroxychloroquine treatment in COVID‐19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China

Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic

Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic

Antiretroviral HIV drugs in COVID-19 research: promises and risks. An opinion piece

Antiretroviral HIV drugs in COVID‐19 research: promises and risks. An opinion piece

Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of COVID-19: Psychopharmacological Interactions and Neuropsychiatric Sequelae

Targeting the SARS-CoV-2 Main Protease to Repurpose Drugs for COVID-19

Chloroquine and hydroxychloroquine for the treatment of COVID-19: A living systematic review protocol

Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy

Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital

A New Drug-Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study

A New Drug–Drug Interaction Between Hydroxychloroquine and Metformin? A Signal Detection Study

Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-Analysis

The immunology of COVID-19: is immune modulation an option for treatment?

Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics

Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence

Chloroquine paradox may cause more damage than help fight COVID-19

When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?

Doubtful precipitation of hemolysis by hydroxychloroquine in glucose‐6‐phosphate dehydrogenase deficient patient with COVID‐19 infection

Doubtful precipitation of hemolysis by hydroxychloroquine in glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection

National Consumption of Antimalarial Drugs and COVID-19 Deaths Dynamics : an Ecological Study

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.

Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial

Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19

Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)

Systematic Review and Meta-analysis of the Effectiveness and Safety of Hydroxychloroquine in COVID-19.

COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine

Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence

Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence

Safety considerations of chloroquine and hydroxychloroquine in treatment of COVID-19

Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks

Plasma IL-6 Levels following Corticosteroid Therapy as an Indicator of ICU Length of Stay in Critically ill COVID-19 Patients


Question: which SARS-CoV-2 proteins-human proteins interactions indicate potential for drug targets. Are there approved drugs that can be repurposed based on this information?

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study

Network-based Drug Repurposing for Human Coronavirus

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing

A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease

Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple SARS-CoV-2 proteins.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19

Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection

Identifying Human Interactors of SARS-CoV-2 Proteins and Drug Targets for COVID-19 using Network-Based Label Propagation

Genetic architecture of host proteins interacting with SARS-CoV-2

Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19

Virtual Screening of Plant Metabolites against Main protease, RNA-dependent RNA polymerase and Spike protein of SARS-CoV-2: Therapeutics option of COVID-19

Predicting potential drug targets and repurposable drugs for COVID-19 via a deep generative model for graphs

Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics

Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics

Docking study of Chloroquine and Hydroxychloroquine interaction with SARS-CoV-2 spike glycoprotein-An in silico insight into the comparative efficacy of repurposing antiviral drugs.

Molecular docking and binding mode analysis of selected FDA approved drugs against COVID-19 selected key protein targets: An effort towards drug repurposing to identify the combination therapy to combat COVID-19

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay

In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing

Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden

Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy

The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2

Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening

Eltrombopag is a potential target for drug intervention in SARS-CoV-2 spike protein

Repurposing low–molecular-weight drugs against the main protease of severe acute respiratory syndrome coronavirus 2

Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target

Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an in silico insight into the comparative efficacy of repurposing antiviral drugs

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome

State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2

Perspectives for repurposing drugs for the coronavirus disease 2019

RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis

Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics

Prioritisation of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.

Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach

Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs

iBioProVis: Interactive Visualization and Analysis of Compound Bioactivity Space.

iBioProVis: Interactive Visualization and Analysis of Compound Bioactivity Space

Genetically informed precision drug repurposing for lung function and implications for respiratory infection

CANDO and the infinite drug discovery frontier.

SAveRUNNER: a network-based algorithm for drug repurposing and its application to COVID-19

Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study

Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase

Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

Machine-Learning Driven Drug Repurposing for COVID-19

SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine

Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review

Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review

Current status of COVID-19 therapies and drug repositioning applications

Current Status of COVID-19 Therapies and Drug Repositioning Applications

Antiviral Drug Screen of Kinase inhibitors Identifies Cellular Signaling Pathways Critical for SARS-CoV-2 Replication

Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 Via Integrated Computational Approach.

Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach

COVID-19: Drug Targets and Potential Treatments

Ca2+ Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity

Identification of potential inhibitors of three key enzymes of SARS-CoV2 using computational approach

Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studies

Causal Network Models of SARS-CoV-2 Expression and Aging to Identify Candidates for Drug Repurposing

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

Structural Basis of the SARS-CoV-2/SARS-CoV Receptor Binding and Small-Molecule Blockers as Potential Therapeutics.

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Insight Derived from Molecular Docking and Molecular Dynamics Simulations into the Binding Interactions Between HIV-1 Protease Inhibitors and SARS-CoV-2 3CLpro

Identification of Repurposal Drugs and Adverse Drug Reactions for Various Courses of Coronavirus Disease 2019 (COVID-19) Based on Single-cell RNA Sequencing Data

Stilbene-based natural compounds as promising drug candidates against COVID-19

Knowledge‐based structural models of SARS‐CoV‐2 proteins and their complexes with potential drugs

Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model

GraphDTA: Predicting drug–target binding affinity with graph neural networks

Computational modeling of Human-nCoV protein-protein interaction network

Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19.

Corona virus versus existence of human on the earth: A computational and biophysical approach

Hijacking SARS-Cov-2/ACE2 receptor interaction by natural and semi-synthetic steroidal agents acting on functional pockets on receptor binding region

The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19

Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an in silico based approach.


Question: is remdesivir an effective treatment for COVID-19

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.

Remdesivir in treatment of COVID-19: A systematic benefit-risk assessment

Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis

Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies

Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment

Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More

A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.

Efficacy and Safety of Remdesivir for COVID-19 Treatment: An Analysis of Randomized, Double-Blind, Placebo-Controlled Trials

Remdesivir Efficacy in Coronavirus Disease 2019 (COVID-19): A Systematic Review

Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

The journey of remdesivir: from Ebola to COVID-19

Impacts of remdesivir on dynamics and efficacy stratified by the severity of COVID-19: a simulated two-arm controlled study

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit

Remdesivir use in patients with coronavirus COVID-19 disease: a systematic review and meta-analysis

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Delayed Initiation of Remdesivir in a COVID-19-Positive Patient

Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient

Early experience with remdesivir in SARS-CoV-2 pneumonia

Role of 1’-Ribose Cyano Substitution for Remdesivir to Effectively Inhibit both Nucleotide Addition and Proofreading in SARS-CoV-2 Viral RNA Replication

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase

Current Evidence of the Pharmacological Treatments for Novel Coronavirus Disease 2019 (COVID-19) A Scoping Review

Case reports study of the first five patients COVID-19 treated with remdesivir in France

Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19).

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.

Emerging Treatment and Prevention Strategies against COVID-19: A Brief Update

Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses

Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials

COVID-19: The Potential Role of Copper and N-acetylcysteine (NAC) in a Combination of Candidate Antiviral Treatments Against SARS-CoV-2.

Remdesivir data offer hope, with caveats

Scaling up remdesivir amid the coronavirus crisis

Remdesivir for the Treatment of Covid-19 - Preliminary Report

Remdesivir for the Treatment of Covid-19 — Preliminary Report

Statistical Issues and Lessons Learned from COVID-19 Clinical Trials with Lopinavir-Ritonavir and Remdesivir

Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Current pharmacological treatments for SARS-COV-2: A narrative review

Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary

In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease

Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia

Antivirals for COVID-19.

Geneesmiddelen bij COVID-19./ [Medication and comedication in COVID-19 patients]

Rapid review for the anti-coronavirus effect of remdesivir.

Rapid review for the anti-coronavirus effect of remdesivir

The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status

Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis

Can Zn Be a Critical Element in COVID-19 Treatment?

That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19

[Medication and comedication in COVID-19 patients].

Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection

Compassionate Use of Remdesivir for Patients with Severe Covid-19

How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19

Treatment options for COVID-19: the reality and challenges

Treatment options for COVID-19: The reality and challenges

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status

Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition

Pharmacotherapy in COVID-19; A narrative review for emergency providers

Antiviral treatment of COVID-19

Antiviral treatment of COVID-19

Harmonizing heterogeneous endpoints in COVID-19 trials without loss of information - an essential step to facilitate decision making

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19

Remdesivir inhibits renal fibrosis in obstructed kidneys

Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)

Simeprevir suppresses SARS-CoV-2 replication and synergizes with remdesivir

Old and re-purposed drugs for the treatment of COVID-19

Old and re-purposed drugs for the treatment of COVID-19.

Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19

Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action

SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus


Question: How does the coronavirus differ from seasonal flu?

Experience of a screening centre for influenza A/H1N1: the first 50 days.

Understanding Coronavirus

Pollen Explains Flu-Like and COVID-19 Seasonality

Modelling the Extremes of Seasonal Viruses and Hospital Congestion: The Example of Flu in a Swiss Hospital

The utility of preemptive mass influenza vaccination in controlling a sars outbreak during flu season.

Development and verification of real-time PCR assay for identification of viral agents causing acute respiratory infections in human beings

Monitoring Influenza Activity in the United States: A Comparison of Traditional Surveillance Systems with Google Flu Trends

Public views of the uk media and government reaction to the 2009 swine flu pandemic

Forecasting the 2013–2014 Influenza Season Using Wikipedia

Are dental schools adequately preparing dental students to face outbreaks of infectious diseases such as COVID‐19?

Are dental schools adequately preparing dental students to face outbreaks of infectious diseases such as COVID-19?

Environmental factors and seasonal influenza onset in Okayama city, Japan: case-crossover study.

Subsequent waves of viral pandemics, a hint for the future course of the SARS-CoV-2 pandemic.

Initial psychological responses to Influenza A, H1N1 ("Swine flu")

ORBiT: Oak Ridge biosurveillance toolkit for public health dynamics

Influenza species and subtypes circulation among hospitalized patients in Laleh hospital during two influenza seasonal (2016-2017 and 2017-2018) using a multiplex Real Time-Polymerase Chain Reaction

Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts, hay fever and flu-like incidence 2016-2019

Incidence and seasonality of respiratory viruses causing acute respiratory infections in the Northern United Arab Emirates

Pollen likely seasonal factor in inhibiting flu-like epidemics. A Dutch study into the inverse relation between pollen counts, hay fever and flu-like incidence 2016–2019

SARS vs. flu: can you tell serious disease from common malady?

Does this patient have COVID-19? A practical guide for the internist

Traumatic Times

The complex associations of climate variability with seasonal influenza A and B virus transmission in subtropical Shanghai, China

Analyses of Merging Clinical and Viral Genetic Data for Influenza Surveillance.

Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020

Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic

Typical epidemiology of respiratory virus infections in a Brazilian slum

An econometric analysis of SARS and Avian Flu on international tourist arrivals to Asia

News coverage of health-related issues and its impacts on perceptions: Taiwan as an example.

Factors in vaccination intention against the pandemic influenza A/H1N1

Hospital Associated Respiratory Virus Infection in Children and Adults: It Does Not Just Occur During Cold and Flu Season

Assessing the interactions between COVID-19 and influenza in the United States

Relative disease burdens of COVID-19 and seasonal influenza in New York City, February 1 - April 18, 2020.

Ingestion of Exopolymers from Aureobasidium pullulans Reduces the Duration of Cold and Flu Symptoms: A Randomized, Placebo-Controlled Intervention Study

Flu or a Bug?

Does subsidy work? Price elasticity of demand for influenza vaccination among the elderly in Japan

Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children

Reproduction of East-African bats may guide risk mitigation for coronavirus spillover

Prevalence of respiratory viruses, including newly identified viruses, in hospitalised children in Austria

Modeling the impact of mass influenza vaccination and public health interventions on COVID-19 epidemics with limited detection capability

Fevers Are Rarest in the Morning: Could We Be Missing Infectious Disease Cases by Screening for Fever Then?

Immunohistochemical assessment of respiratory viruses in necropsy samples from lethal non-pandemic seasonal respiratory infections.

Online Social Networks Flu Trend Tracker: A Novel Sensory Approach to Predict Flu Trends

Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza

Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season

Swine flu update: bringing home the bacon.

Human temperatures for syndromic surveillance in the emergency department: data from the autumn wave of the 2009 swine flu (H1N1) pandemic and a seasonal influenza outbreak

H1N1 viral proteome peptide microarray predicts individuals at risk for H1N1 infection and segregates infection versus Pandemrix® vaccination

Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project – Monitoring Vaccine Effectiveness (I-MOVE)

Talking about colds and flu: The lay diagnosis of two common illnesses among older British people

Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995.

Featuring COVID-19 cases via screening symptomatic patients with epidemiologic link during flu season in a medical center of central Taiwan

Measuring COVID-19 and Influenza in the Real World via Person-Generated Health Data

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies

A close look at the biology of SARS-CoV-2, and the potential influence of weather conditions and seasons on COVID-19 case spread

A Model for Characterizing Annual Flu Cases

Evaluating the diagnostic accuracy of the WHO Severe Acute Respiratory Infection (SARI) criteria in Middle Eastern children under two years over three respiratory seasons

Comparison of the fecal microbiota of domestic commercial meat, laboratory, companion, and shelter rabbits (Oryctolagus cuniculi)

Impacts of rapid flu clinic services at an emergency department during the pandemic flu season

Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping

Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes

Hajj-associated infections

Social Distancing and Personal Protective Measures Decrease Influenza Morbidity and Mortality

High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults

Influenza A non-H1N1 associated with acute respiratory failure and acute renal failure in a previously vaccinated cystic fibrosis patient

Characterising the epidemic spread of Influenza A/H3N2 within a city through phylogenetics

The impact of media coverage on the transmission dynamics of human influenza

Viral Etiology of Acute Respiratory Infection in Gansu Province, China, 2011

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic.

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

How diseases rise and fall with the seasons—and what it could mean for coronavirus

Estimating the Early Outbreak Cumulative Incidence of COVID-19 in the United States: Three Complementary Approaches

Health Information–Seeking Patterns of the General Public and Indications for Disease Surveillance: Register-Based Study Using Lyme Disease

The Pace and Pulse of the Fight against Coronavirus across the US, A Google Trends Approach

Influenza as a model system for studying the cross-species transfer and evolution of the SARS coronavirus.

Using web search queries to monitor influenza-like illness: an exploratory retrospective analysis, Netherlands, 2017/18 influenza season

How Should the Rehabilitation Community Prepare for 2019-nCoV?

How necessary is a fast testkit for mitigation of pandemic flu?

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS

Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients—Lessons Learned From SARS and MERS

Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India

Prevalence of Flu-like Symptoms and COVID-19 in Healthcare Workers from India.

Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza

Self-Swabbing for Virological Confirmation of Influenza-Like Illness Among an Internet-Based Cohort in the UK During the 2014-2015 Flu Season: Pilot Study

Viral pathogens of acute lower respiratory tract infection in China.

Are coinfections with COVID-19 and influenza low or underreported? An observational study examining current published literature including three new unpublished cases

From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging Pathogens

Human coronaviruses: what do they cause?

The contribution of respiratory pathogens to the seasonality of NHS Direct calls

Creating a comprehensive multi-tiered influenza management plan for a large healthcare system

Animals and coronavirus, help for African labs and a short flu season

Reassuring and managing patients with concerns about swine flu: Qualitative interviews with callers to NHS Direct

Patterns of mortality during pandemic: An example of Spanish flu pandemic of 1918

Towards a data-driven characterization of behavioral changes induced by the seasonal flu


Question: Does SARS-CoV-2 have any subtypes, and if so what are they?

Masking the general population might attenuate COVID-19 outbreaks

Is SARS-CoV-2 Vertically Transmitted?

Genetic Grouping of SARS-CoV-2 Coronavirus Sequences using Informative Subtype Markers for Pandemic Spread Visualization

SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?

Podcast: Beating a killer coronavirus

Understanding Coronavirus

The Coronavirus Pandemic: What Does the Evidence Show?

In the pipeline Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. All content is Derek’s own, and he does not in any way speak for his employer

In silico multi-epitope vaccine against covid19 showing effective interaction with HLA-B*15:03

A Novel Synonymous Mutation of SARS-CoV-2: Is This Possible to Affect Their Antigenicity and Immunogenicity?

Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?

What we know about the novel coronavirus’s proteins

Are your cash-flow tools recession ready?

GPS Tracking App for Police to Track Ambulances Carrying COVID-19 Patients for Ensuring Safe Distancing

Aerosol generating procedures and infective risk to healthcare workers: SARS-CoV-2 – the limits of the evidence

Aerosol generating procedures and infective risk to healthcare workers: SARS-CoV-2 - the limits of the evidence

Ultraviolet irradiation doses for coronavirus inactivation – review and analysis of coronavirus photoinactivation studies

Severe Acute Respiratory Syndrome Coronavirus Elicits a Weak Interferon Response Compared to Traditional Interferon-Inducing Viruses

Implications for forensic death investigations from first Swiss post-mortem CT in a case of non-hospital treatment with COVID-19

What’s new in the renin-angiotensin system?: Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus

Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M.

Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?

The global population of SARS-CoV-2 is composed of six major subtypes

What's the plan? The unique challenges facing the home and community care sector in preparing for a pandemic.

Does SARS-CoV-2 has a longer incubation period than SARS and MERS?

Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS?

The SARS-CoV-2 receptor, Angiotensin converting enzyme 2 (ACE2) is required for human endometrial stromal cell decidualization

Mutations strengthened SARS-CoV-2 infectivity

Mutations on COVID-19 diagnostic targets

Meaning of dangerous goods

BCG is a good immunotherapeutic agent for viral and autoimmune diseases: Is it a new weapon against coronavirus (COVID-19)?

Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far

Coronavirus in pregnancy. What we know so far?

The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis

Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes

SARS-CoV-2, COVID-19, skin and immunology - what do we know so far?

A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection

Protective immunity after COVID-19 has been questioned: What can we do without SARS-CoV-2-IgG detection?

Protective immunity after COVID-19 has been questioned: what can we do without SARS-CoV-2-IgG detection?

Host Immune Response and Immunobiology of Human SARS-CoV-2 Infection

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

Revealing variants in SARS-CoV-2 interaction domain of ACE2 and loss of function intolerance through analysis of >200,000 exomes

A generalized overview of SARS-COV-2: Where does the current knowledge stand?

SARS-CoV-2 and human milk: what is the evidence?

No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2

Replication of SARS-CoV-2 in human respiratory epithelium.

Replication of SARS-CoV-2 in human respiratory epithelium

Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models

[What is the origin of SARS-CoV-2?]

Enfermedad pulmonar obstructiva crónica e infección por SARS-CoV-2. ¿Qué sabemos hasta ahora?/ Enfermedad pulmonar obstructiva crónica e infección por SARS-CoV-2. ¿Qué sabemos hasta ahora?/ Chronic Obstructive Pulmonary Disease and SARS-CoV-2 Infection. What Do We Know so Far?

Extrapulmonary Manifestations of SARS-CoV-2: A Brief Review

Effects of COVID-19 Infection during Pregnancy and Neonatal Prognosis: What Is the Evidence?

Discharged COVID-19 Patients Testing Positive Again for SARS-CoV-2 RNA: A Minireview of Published Studies from China

Discharged COVID‐19 Patients Testing Positive Again for SARS‐CoV‐2 RNA: A Minireview of Published Studies from China

Current laboratory diagnostics of coronavirus disease 2019 (COVID-19).

Coronavirus Disease (COVID-19) in Children - What We Know So Far and What We Do Not?

Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not

On the sensitivity of non-pharmaceutical intervention models for SARS-CoV-2 spread estimation

Treatment and research lines for the patient with COVID-19. What do we have and where are we going?

Why does Japan have so few cases of COVID-19?

An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies

Biological Warfare: Infectious Disease and Bioterrorism

COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

Why does the coronavirus spread so easily between people?

What we know so far: COVID-19 current clinical knowledge and research.

Why does Japan have so few cases of COVID‐19?

Patient DNA cross-reactivity of the CDC SARS-CoV-2 extraction control leads to an inherent potential for false negative results

Sars-CoV-2: A clinical update - II

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Dermatologists and SARS‐CoV‐2: The impact of the pandemic on daily practice

Dermatologists and SARS-CoV-2: the impact of the pandemic on daily practice

COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions

On the evolutionary epidemiology of SARS-CoV-2

Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes

In silico prediction of potential inhibitors for the Main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing

Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.

Fight against novel coronavirus: A perspective of medicinal chemists

INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.

Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination

Novel coronavirus SARS-CoV-2 and COVID-19. Practice recommendations for obstetric anaesthesia: what we have learned thus far

SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review

Potential for elimination of SAR‐CoV‐2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination

Epidemiological and clinical features of asymptomatic patients with SARS‐CoV‐2 infection

Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection

Neurological Insights of COVID-19 Pandemic

Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.

COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?

SARS‐CoV‐2: What do we know so far?

Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.


Question: What vaccine candidates are being tested for Covid-19?

SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.

Drug Repurposing to find Inhibitors of SARS-CoV-2 Main Protease

Mapping the Immunodominance Landscape of SARS-CoV-2 Spike Protein for the Design of Vaccines against COVID-19

Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials

The potential danger of suboptimal antibody responses in COVID-19

From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?

Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus.

Another Set of Coronavirus Vaccine Candidates

Consensus Summary Report for CEPI/BC March 12-13, 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines

Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

Products in a Pandemic: Liability for Medical Products and the Fight against COVID-19

Molecular Pathogenesis of Middle East Respiratory Syndrome (MERS) Coronavirus

Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)

Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines

Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines

A review on possible modes of actions of Chloroquine/ Hydroxychloroquine: Repurposing against SAR-COV-2 (COVID 19) pandemic

A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities

What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?

Current Therapies Under Investigation for COVID-19

Current Therapies Under Investigation for COVID-19.

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

National Consumption of Antimalarial Drugs and COVID-19 Deaths Dynamics : an Ecological Study

The potential of cannabidiol in the COVID-19 pandemic: a hypothesis letter

The potential of cannabidiol in the COVID‐19 pandemic: a hypothesis letter

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines

Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients

The Importance of Animal Models in the Development of Vaccines

Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus

Mental Health Care Providers Dealing With Coronavirus Disease 2019 (COVID-19): What Is the Definition of a Case, How Is That Changing, and What Kinds of Tests Are Available?

Zika Virus: What Have We Learnt Since the Start of the Recent Epidemic?

Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials.

SARS-CoV-2 in urine. - Should Endourologists be concerned and what PPE measures should be taken to protect the Endourologist when in theatre ?

Covid-19 treatment: The race against time

Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products

Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events

Why Challenge Trials of SARS-CoV-2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events

How Close are We to a COVID-19 Vaccine?

Dose-dependent response to infection with SARS-CoV-2 in the ferret model: evidence of protection to re-challenge

Pharmacologicaltreatment of COVID-19: lights and shadows

Potential therapeutic agents against COVID-19: What we know so far

Neue Impfstoffe gegen Tuberkulose

COVID-19 Vaccine Candidates: Prediction and Validation of 174 SARS-CoV-2 Epitopes

IgY - turning the page toward passive immunization in COVID-19 infection (Review)

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

Contingent assessment of the COVID-19 vaccine

COVID-19: Learning from Lessons To Guide Treatment and Prevention Interventions

COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning

in-silica Analysis of SARS-CoV-2 viral strain using Reverse Vaccinology Approach: A Case Study for USA

A Scalable Topical Vectored Vaccine Candidate Against SARS-CoV-2

Criticism of the Oxford Coronavirus Vaccine

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2

COVID-19 vaccines move toward clinic

SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward

Development of an inactivated vaccine candidate for SARS-CoV-2

[At least 68 vaccine candidates under development].

An overview on COVID-19: reality and expectation

[Coronavirus, emerging viruses].

Vaccines for COVID-19: the current state of play

Vaccines for COVID-19: The current state of play

Elucidation on the Physicochemical Properties of Potential and Clinically Approved Antiviral Drugs: A Search for Effective Therapies against SARS-CoV-2 Infection

Natural History of COVID-19 and Current Knowledge on Treatment Therapeutic Options

Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria

TB Prevalence Correlation to Covid- 19 Mortality

SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both respiratory and gastrointestinal tracts

Immunogenicity of a DNA vaccine candidate for COVID-19

Adjusting Coronavirus prevalence estimates for laboratory test kit error

A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate

COVID-19 Comes 40 Years After AIDS - Any Lesson?

Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening

Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar

Vaccination against the Epstein–Barr virus

Ethical considerations for epidemic vaccine trials

A SARS-CoV-2 vaccine candidate: In silico cloning and validation

At the heart of COVID-19.

At the heart of COVID-19

In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform

Identification of peptide candidate against COVID-19 through reverse vaccinology: An immunoinformatics approach

A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.

COVID-19 research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine

SARS-CoV-2: A New Song Recalls an Old Melody

Pandemic Best Regulatory Practices: An Urgent Need in the COVID-19 Pandemic

A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic

Testing for tracing or testing just for treating? A comparative analysis between strategies to face COVID-19 pandemic.

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review

Microstructure, pathophysiology and potential therapeutics of COVID‐19: A comprehensive review

A Highly Immunogenic Measles Virus-based Th1-biased COVID-19 Vaccine

Emerging Pharmaceutical Treatments of Novel COVID-19: A Review


Question: What are the longer-term complications of those who recover from COVID-19?

Intervention Serology and Interaction Substitution: Modeling the Role of ‘Shield Immunity’ in Reducing COVID-19 Epidemic Spread

A Case of COVID-19 Infection With Delayed Thromboembolic Complication on Warfarin

Laboratory findings that predict a poor prognosis in COVID-19 patients with diabetes: A meta-analysis

Recovering from the COVID-19 Pandemic: A Focus on Older Adults

Recovering from the COVID-19 Pandemic: A Focus on Older Adults.

What are the functional results and complications from allograft reconstruction after partial hemipelvectomy of the pubis?

Behavioral Health and Response for COVID-19

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study

Significance of prophylactic intra-abdominal drain placement after laparoscopic distal gastrectomy for gastric cancer.

Report of a series of healthy term newborns from convalescent mothers with COVID-19.

Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China

Considerations for Postacute Rehabilitation for Survivors of COVID-19

The impact of nutrition on COVID-19 susceptibility and long-term consequences

Supporting Adults Bereaved Through COVID-19: A Rapid Review of the Impact of Previous Pandemics on Grief and Bereavement

[SARS-CoV-2 infection (COVID-19): what can we expect?]

Covid-19: accelerating recovery

Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China

Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China

What is the best drug to treat COVID-19? The need for randomized controlled trials

To recover faster from Covid-19, open up: Managerial implications from an open innovation perspective

Supporting adults bereaved through COVID-19: a rapid review of the impact of previous pandemics on grief and bereavement

Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.

Laparoscopic common bile duct exploration in patients with complicated cholecystitis: a safety and feasibility study.

Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients’ Recovery

Clinical characteristics and chest CT imaging features of critically ill COVID-19 patients

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients

Incomplete and late recovery of sudden olfactory dysfunction in COVID-19()

Short-Term Outcomes of Laparoscopic Total Gastrectomy Performed by a Single Surgeon Experienced in Open Gastrectomy: Review of Initial Experience.

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Incomplete and late recovery of sudden olfactory dysfunction in COVID-19

Needs of individuals recovering from a first episode of mental illness: A scoping review.

Endoscopic Thyroidectomy Using the Unilateral Axillo-breast Approach Versus the Modified Anterior Chest Wall Approach: A Prospective Comparative Study.

High prevalence of disordered eating behavior in Danish children and adolescents with type 1 diabetes.

Evaluation of patients undergoing abdominal sacrocolpopexy due to symptomatic pelvic organ prolapse in terms of gastrointestinal complications.

Taking the Longer View of COVID‐19

Medium-Term Results of Laparoscopic Sleeve Gastrectomy: a Matched Comparison with Gastric Bypass.

Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression

Successful recovery of COVID‐19 pneumonia in a renal transplant recipient with long‐term immunosuppression

Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.

Robotic assisted gastrectomy compared with open resection: a case-matched study.

Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection

Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation.

Emergence of Novel Coronavirus and COVID-19: whether to stay or die out?

The safety of Pipeline flow diversion in fusiform vertebrobasilar aneurysms: a consecutive case series with longer-term follow-up from a single US center.

Coronavirus: Short‐term pain but strong rebound likely

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Hand-assisted technique facilitates preserving graft viability in laparoscopic donor nephrectomy.

Case fatality risk of the first pandemic wave of novel coronavirus disease 2019 (COVID-19) in China

Does immune privilege result in recovered patients testing positive for COVID-19 again?

Healthcare workers experiences of working on the frontline and views about support during COVID-19 and comparable pandemics: A rapid review and meta-synthesis

Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China

Improved survival outcome in SARs-CoV-2 (COVID-19) Acute Respiratory Distress Syndrome patients with Tocilizumab administration

Short-term outcomes for robotic colorectal surgery by provider volume.

In the eye of the beholder: to make global health estimates useful, make them more socially robust.

Searching for a coronavirus cure in the blood

Intestinal/Multivisceral Transplantation

COVID‐19 Pandemic and Its Impact on the Global Economy: What Does It Take to Turn Crisis into Opportunity?

A short or a long Roux limb in gastric bypass surgery: does it matter?

Characteristics and serological patterns of COVID‐19 convalescent plasma donors: optimal donors and timing of donation

Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation

Encountering COVID-19 as Endocrinologists.

Encountering COVID-19 as Endocrinologists

Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with COVID-19

What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism.

Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves.

Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV

Long-term production effects of clinical cryptosporidiosis in neonatal calves

Health Equity, Social Policy, and Promoting Recovery from COVID-19.

Health Equity, Social Policy, and Promoting Recovery from COVID-19

Quantifying Projected Impact of Social Distancing Policies on COVID-19 Outcomes in the US

COVID-19: The potential treatment of pulmonary fibrosis associated with SARS-CoV-2 infection

The Decreasing Incidence of Acute Appendicitis During COVID-19: A Retrospective Multi-centre Study

Cardiac complications in community-acquired pneumonia and COVID-19

Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With COVID-19

A mathematical model to guide the re-opening of economies during the COVID-19 pandemic

Predictions, role of interventions and effects of a historic national lockdown in India's response to the COVID-19 pandemic: data science call to arms

Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study

Laparoscopic surgical treatment of ileocecal Crohn's disease: Impact of obesity on short term results.

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Measuring COVID-19 and Influenza in the Real World via Person-Generated Health Data

Being HIV positive and staying on antiretroviral therapy in Africa: A qualitative systematic review and theoretical model.

Acute Care Surgery during the COVID-19 pandemic in Spain: changes in volume, causes and complications. A multicentre retrospective cohort study

Demographic and Clinical Characteristics of the Severe Covid-19 Infections: First Report from Mashhad University of Medical Sciences, Iran

COVID-19 compassion in self-isolating old age: looking forward from family to regional and global concerns

A Letter to the Future AWWA

Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.

Short-term outcomes of laparoscopic versus open total gastrectomy: a matched-cohort study.


Question: What new public datasets are available related to COVID-19?

Does Non-COVID19 Lung Lesion Help? Investigating Transferability in COVID-19 CT Image Segmentation

Lest We Forget: A Dataset of Coronavirus-Related News Headlines in Swiss Media

CoAID: COVID-19 Healthcare Misinformation Dataset

Public Opinions towards COVID-19 in California and New York on Twitter

Automatic Text Summarization of COVID-19 Medical Research Articles using BERT and GPT-2

Unveiling COVID-19 from Chest X-ray with deep learning: a hurdles race with small data

Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes

Open access institutional and news media tweet dataset for COVID-19 social science research

POCOVID-Net: Automatic Detection of COVID-19 From a New Lung Ultrasound Imaging Dataset (POCUS)

Recognizing flu-like symptoms from videos

Statistical Explorations and Univariate Timeseries Analysis on COVID-19 Datasets to Understand the Trend of Disease Spreading and Death

A First Instagram Dataset on COVID-19

Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov’s complexity and Shannon’s information theories

Rapidly Bootstrapping a Question Answering Dataset for COVID-19

Automated Chest CT Image Segmentation of COVID-19 Lung Infection based on 3D U-Net

A curated transcriptome dataset collection to investigate the blood transcriptional response to viral respiratory tract infection and vaccination.

Visualising COVID-19 Research

Covid-19: automatic detection from X-ray images utilizing transfer learning with convolutional neural networks

CoronaVis: A Real-time COVID-19 Tweets Data Analyzer and Data Repository

On the Generation of Medical Dialogues for COVID-19

NAIST COVID: Multilingual COVID-19 Twitter and Weibo Dataset

Coronaviruses and people with intellectual disability: an exploratory data analysis

Integrated Time Series Summarization and Prediction Algorithm and its Application to COVID-19 Data Mining

Deep Learning for Screening COVID-19 using Chest X-Ray Images

FakeCovid -- A Multilingual Cross-domain Fact Check News Dataset for COVID-19

Unique transcriptional changes in coagulation cascade genes in SARS-CoV-2-infected lung epithelial cells: A potential factor in COVID-19 coagulopathies

Understand Research Hotspots Surrounding COVID-19 and Other Coronavirus Infections Using Topic Modeling

Collective response to the media coverage of COVID-19 Pandemic on Reddit and Wikipedia

Policy response, social media and science journalism for the sustainability of the public health system amid the COVID-19 outbreak: The vietnam lessons

CO-Search: COVID-19 Information Retrieval with Semantic Search, Question Answering, and Abstractive Summarization

Advertisers Jump on Coronavirus Bandwagon: Politics, News, and Business

Identification of spatial variations in COVID-19 epidemiological data using K-Means clustering algorithm: a global perspective

Comprehensive Named Entity Recognition on CORD-19 with Distant or Weak Supervision

Artificial Intelligence and COVID-19: A Multidisciplinary Approach

Frequency of testing for COVID 19 infection and the presence of higher number of available beds per country predict outcomes with the infection, not the GDP of the country - A descriptive statistical analysis

A critical analysis of corona related data: What the more reliable data can imply for Western-Europe

Twitter sentiment classification for measuring public health concerns

Preliminary analysis of COVID-19 academic information patterns: a call for open science in the times of closed borders

What is the people posting about symptoms related to Coronavirus in Bogota, Colombia?

On the Generation of Medical Dialogues for COVID-19

A large-scale COVID-19 Twitter chatter dataset for open scientific research -- an international collaboration.

Daily growth rate of scientific production on Covid-19. Analysis in databases and open access repositories

Understanding Economic and Health Factors Impacting the Spread of COVID-19 Disease

A Look at the First Quarantined Community in the USA: Response of Religious Communal Organizations and Implications for Public Health During the COVID-19 Pandemic

COVID-19: What are the risks in hypertensive patients?

Classification Aware Neural Topic Model and its Application on a New COVID-19 Disinformation Corpus

Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study

BIP4COVID19: Releasing impact measures for articles relevant to COVID-19

CoV-Seq: SARS-CoV-2 Genome Analysis and Visualization

CoroNet: A Deep Neural Network for Detection and Diagnosis of COVID-19 from Chest X-ray Images

CoroNet: A deep neural network for detection and diagnosis of COVID-19 from chest x-ray images

Towards Efficient COVID-19 CT Annotation: A Benchmark for Lung and Infection Segmentation

Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group

TweetsCOV19 -- A Knowledge Base of Semantically Annotated Tweets about the COVID-19 Pandemic

Enhanced COVID-19 data for improved prediction of survival

COVID-19 Detection in Chest X-ray Images using a Deep Learning Approach

Analysis of temporal trends in potential COVID-19 cases reported through NHS Pathways England

COVID-19-CT-CXR: a freely accessible and weakly labeled chest X-ray and CT image collection on COVID-19 from biomedical literature.

$\alpha$-Satellite: An AI-driven System and Benchmark Datasets for Hierarchical Community-level Risk Assessment to Help Combat COVID-19

Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells

Emergence of COVID-19 Infection: What Is Known and What Is to Be Expected-Narrative Review Article

A County-level Dataset for Informing the United States' Response to COVID-19

Fast and accurate detection of Covid-19-related pneumonia from chest X-ray images with novel deep learning model

The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis

COVID-CT-Dataset: A CT Scan Dataset about COVID-19

A COVID-19 epidemic model integrating direct and fomite transmission as well as household structure

A Cascaded Learning Strategy for Robust COVID-19 Pneumonia Chest X-Ray Screening

A citizen science initiative for open data and visualization of COVID-19 outbreak in Kerala, India

Semiparametric Bayesian Inference for the Transmission Dynamics of COVID-19 with a State-Space Model

Predicting the epidemic curve of the coronavirus (SARS-CoV-2) disease (COVID-19) using artificial intelligence

Exploring Epidemiological Behavior of Novel Coronavirus Outbreak through the Development and Analysis of COVID-19 Daily Dataset in Bangladesh

Clustering of Covid-19 morbidity cases in Germany

Tracking Public Opinion in China through Various Stages of the COVID-19 Pandemic

Oscillations in USA COVID-19 Incidence and Mortality Data reflect societal factors

COVID-19 virus outbreak lockdown: What impacts on household food wastage?

Momentum Contrastive Learning for Few-Shot COVID-19 Diagnosis from Chest CT Images

Informative Ranking of Stand Out Collections of Symptoms: A New Data-Driven Approach to Identify the Strong Warning Signs of COVID 19

What lies ahead: Elevated concerns for the ongoing suicide pandemic

What lies ahead: Elevated concerns for the ongoing suicide pandemic.

COVID-Net: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest X-Ray Images

Open Access and Altmetrics in the pandemic age: Forescast analysis on COVID-19 literature

Feature sensitivity criterion-based sampling strategy from the Optimization based on Phylogram Analysis (Fs-OPA) and Cox regression applied to mental disorder datasets.

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data

Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates

iBioProVis: Interactive Visualization and Analysis of Compound Bioactivity Space.

COVID-19 and Headache: A Primer for Trainees

New blood tests for antibodies could show true scale of coronavirus pandemic

CoroNet: A Deep Network Architecture for Semi-Supervised Task-Based Identification of COVID-19 from Chest X-ray Images

Mapping the South African health landscape in response to COVID-19

What Is Required to Prevent a Second Major Outbreak of SARS-CoV-2 upon Lifting Quarantine in Wuhan City, China

Modeling the Spread of COVID-19 Infection Using a Multilayer Perceptron


Question: What is the protein structure of the SARS-CoV-2 spike?

Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2

Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2

Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein

Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike protein

N-glycosylation network construction and analysis to modify glycans on the spike S glycoprotein of SARS-CoV-2

Adding the missing sugars to coronavirus protein structures

N and O glycosylation of the SARS-CoV-2 spike protein

Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.

Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein

Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes

Shielding and Beyond: The Roles of Glycans in SARS-CoV-2 Spike Protein

The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach

Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition

CoV3D: A database of high resolution coronavirus protein structures

Identification of conserved epitopes in SARS-CoV-2 spike and nucleocapsid protein

Evolutionary relationships and sequence‐structure determinants in human SARS coronavirus‐2 spike proteins for host receptor recognition

SARS-CoV-2 mutations and where to find them: An in silico perspective of structural changes and antigenicity of the Spike protein

A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies

Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights and Implications for the Design of Diagnostics and Therapeutics

Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.

Investigation of the effect of temperature on the structure of SARS-Cov-2 Spike Protein by Molecular Dynamics Simulations

Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease

An engineered stable mini-protein to plug SARS-Cov-2 Spikes

Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective

Structure, function and variants analysis of the androgen-regulated TMPRSS2, a drug target candidate for COVID-19 infection

Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Computational simulations reveal the binding dynamics between human ACE2 and the receptor binding domain of SARS-CoV-2 spike protein

Structural Molecular Insights into SARS Coronavirus Cellular Attachment, Entry and Morphogenesis

Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach

Prefusion spike protein stabilization through computational mutagenesis

Distinct Structural Flexibility within SARS-CoV-2 Spike Protein Reveals Potential Therapeutic Targets

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.

Novel ACE2-Independent Carbohydrate-Binding of SARS-CoV-2 Spike Protein to Host Lectins and Lung Microbiota

Structural basis of SARS-CoV-2 spike protein induced by ACE2

Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide

The discovery of potential natural products for targeting SARS-CoV-2 spike protein by virtual screening

The Distal Polybasic Cleavage Sites of SARS-CoV-2 Spike Protein Enhance Spike Protein-ACE2 Binding

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Dynamics of the ACE2 - SARS-CoV/SARS-CoV-2 spike protein interface reveal unique mechanisms

Structural insight into the putative role of novel SARS CoV-2 E protein in viral infection: a potential target for LAV development and therapeutic strategies

Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.

Antigenic evolution on global scale reveals potential natural selection of SARS-CoV-2 by pre-existing cross-reactive T cell immunity

Unexpected free fatty acid binding pocket in the cryo-EM structure of SARS-CoV-2 spike protein

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination

SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development

Systemic Effects of Missense Mutations on SARS-CoV-2 Spike Glycoprotein Stability and Receptor Binding Affinity

Controlling the SARS-CoV-2 Spike Glycoprotein Conformation

A potent neutralizing human antibody reveals the N-terminal domain of the Spike protein of SARS-CoV-2 as a site of vulnerability

From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes

From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes

Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein

Genetic variants in TMPRSS2 and Structure of SARS-CoV-2 spike glycoprotein and TMPRSS2 complex

Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in Spike Glycoprotein

Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor

Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions

Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors

Unveiling diffusion pattern and structural impact of the most invasive SARS-CoV-2 spike mutation

Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins

Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in Colombia

Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission

Minimal system for assembly of SARS-CoV-2 virus like particles

Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop

Molecular architecture of the SARS-CoV-2 virus

Flexibility and mobility of SARS-CoV-2-related protein structures

Understanding the B and T cells epitopes of spike protein of severe respiratory syndrome coronavirus-2: A computational way to predict the immunogens

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Mapping active allosteric loci SARS-CoV Spike Proteins by means of Protein Contact Networks

Insights on cross-species transmission of SARS-CoV-2 from structural modeling

Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity

Comparing the binding interactions in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition

A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV

Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism

Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism

Potential involvement of monoamine oxidase activity in SARS-COV2 infection and delirium onset

Static All-Atom Energetic Mappings of the SARS-Cov-2 Spike Protein with Potential Latch Identification of the Down State Protomer

SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes

How the COVID-19 Overcomes the Battle? An Approach to Virus Structure.

How the COVID-19 Overcomes the Battle? An Approach to Virus Structure

Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD

Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site

Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity

Conformational Reorganization of the SARS Coronavirus Spike Following Receptor Binding: Implications for Membrane Fusion

Properties of Coronavirus and SARS-CoV-2.

Properties of Coronavirus and SARS-CoV-2

Structural and Functional Implications of Spike Protein Mutational Landscape in SARS-CoV-2

Distinct conformational states of SARS-CoV-2 spike protein

SARS-CoV-2 Spike protein variant D614G increases infectivity and retains sensitivity to antibodies that target the receptor binding domain

Whole-Genome Sequences of the Severe Acute Respiratory Syndrome Coronavirus-2 obtained from Romanian patients between March and June of 2020


Question: What is the result of phylogenetic analysis of SARS-CoV-2 genome sequence?

Children’s Hospital Los Angeles COVID-19 Analysis Research Database (CARD) - A Resource for Rapid SARS-CoV-2 Genome Identification Using Interactive Online Phylogenetic Tools

A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis

Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome

Large-Scale Phylogenetic Analysis of Emerging Infectious Diseases

[Analysis on the SARS-CoV genome of PUMC01 isolate].

SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission

A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates

Full-genome sequences of the first two SARS-CoV-2 viruses from India

Phylodynamics of SARS-CoV-2 transmission in Spain

SARS-CoV Infection Was from at Least Two Origins in the Taiwan Area

Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario

Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario.

Phylogenetic analysis of SARS-CoV-2 genomes in Turkey

Phylogenetic Analysis of SARS-CoV-2 Genomes in Turkey

Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition

Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus

Insights into molecular evolution recombination of pandemic SARS-CoV-2 using Saudi Arabian sequences

Evolutionary relationships and sequence‐structure determinants in human SARS coronavirus‐2 spike proteins for host receptor recognition

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe

Genomic surveillance and phylogenetic analysis reveal multiple introductions of SARS-CoV-2 into a global travel hub in the Middle East

Conserved Genomic Terminals of SARS-CoV-2 as Co-evolving Functional Elements and Potential Therapeutic Targets

Phyloevolutionary analysis of SARS-CoV-2 in Nigeria

The UCSC SARS-CoV-2 Genome Browser

Analyzing hCov genome sequences: Applying Machine Intelligence and beyond

Phylogenetic clustering of the Indian SARS-CoV-2 genomes reveals the presence of distinct clades of viral haplotypes among states

Early Phylogenetic Diversification of SARS-CoV-2: Determination of Variants and the Effect on Epidemiology, Immunology, and Diagnostics.

The novel Coronavirus enigma: Phylogeny and mutation analyses of SARS-CoV-2 viruses circulating in India during early 2020

A High-Coverage SARS-CoV-2 Genome Sequence Acquired by Target Capture Sequencing

The complete genome sequence of severe acute respiratory syndrome coronavirus strain HKU-39849 (HK-39).

Genome Analysis of SARS-CoV-2 Isolate from Bangladesh

Phylogenetic analysis of the full‐length SARS‐CoV sequences: Evidence for phylogenetic discordance in three genomic regions

Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel

[Analysis of variation and evolution of SARS-CoV-2 genome]

[Analysis of variation and evolution of SARS-CoV-2 genome].

Quantification of Intra-Host Genomic Diversity of SARS-CoV-2 Allows a High-Resolution Characterization of Viral Evolution and Reveals Functionally Convergent Variants

Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology

A snapshot of SARS-CoV-2 genome availability up to 30th March, 2020 and its implications

Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: A computational biology approach

Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia

Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia

Full genome sequence of the first SARS-CoV-2 detected in Mexico

Monophyletic Relationship between Severe Acute Respiratory Syndrome Coronavirus and Group 2 Coronaviruses

Chasing the origin of SARS-CoV-2 in Canada’s COVID-19 cases: A genomics study

The Novel Coronavirus SARS‐CoV‐2: From a Zoonotic Infection to Coronavirus Disease‐19 (COVID19)

Genetic Grouping of SARS-CoV-2 Coronavirus Sequences using Informative Subtype Markers for Pandemic Spread Visualization

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.

Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world

Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP

A48 Identification and full-genome characterization of Alpha- and Beta-Coronaviruses viruses from bats in Italy

An Analysis of SARS-CoV-2 Using ViReport

Genomic epidemiology of SARS-CoV-2 in Colombia

Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach

The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities.

Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes

Genome-wide data inferring the evolution and population demography of the novel pneumonia coronavirus (SARS-CoV-2)

Identification of diverse alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China.

SARS‐CoV‐2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein

SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein

Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers

SARS-CoV-2 Molecular and Phylogenetic analysis in COVID-19 patients: A preliminary report from Iran

SARS-CoV-2 molecular and phylogenetic analysis in COVID-19 patients: A preliminary report from Iran.

Snapshot of the evolution and mutation patterns of SARS-CoV-2

Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States

First detection and genome sequencing of SARS-CoV-2 in an infected cat in France

First detection and genome sequencing of SARS‐CoV‐2 in an infected cat in France

The novel coronavirus SARS-CoV-2: From a zoonotic infection to coronavirus disease 2019

Comparative Analysis of SARS-CoV2 with Special Emphasis on Genome Sequences

Coding potential and sequence conservation of SARS-CoV-2 and related animal viruses

Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China

Genomics of Indian SARS-CoV-2: Implications in genetic diversity, possible origin and spread of virus

Genomic epidemiology of SARS-CoV-2 spread in Scotland highlights the role of European travel in COVID-19 emergence

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

The establishment of reference sequence for SARS‐CoV‐2 and variation analysis

The establishment of reference sequence for SARS-CoV-2 and variation analysis

Close relationship between SARS-coronavirus and group 2 coronavirus.

Genetic analysis of SARS-CoV-2 strains collected from North Africa: viral origins and mutational spectrum

Insights into The Codon Usage Bias of 13 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Isolates from Different Geo-locations

Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide

Companion vaccine Bioinformatic design tool reveals limited functional genomic variability of SARS-Cov-2 Spike Receptor Binding Domain

Comparing library preparation methods for SARS-CoV-2 multiplex amplicon sequencing on the Illumina MiSeq platform

In-silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs

Multiple SARS-CoV-2 introductions shaped the early outbreak in Central Eastern Europe: comparing Hungarian data to a worldwide sequence data-matrix

Detection of coronaviruses in Pteropus & Rousettus species of bats from different States of India.

The relationship of severe acute respiratory syndrome coronavirus with avian and other coronaviruses.

Genetic Diversity and Genomic Epidemiology of SARS-COV-2 in Morocco

Introductions and early spread of SARS-CoV-2 in France

Origin of imported SARS-CoV-2 strains in The Gambia identified from Whole Genome Sequences

SARS-CoV-2 spread across the Colombian-Venezuelan border

Wild animal surveillance for coronavirus HKU1 and potential variants of other coronaviruses.